经导管瓣膜置换术：风险水平与当代治疗结果
Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes.
作者信息
Reyes Manuel, Reardon Michael J
机构信息
HOUSTON METHODIST DEBAKEY HEART & VASCULAR CENTER, HOUSTON METHODIST HOSPITAL, HOUSTON, TEXAS.
出版信息
Methodist Debakey Cardiovasc J. 2017 Jul-Sep;13(3):126-131. doi: 10.14797/mdcj-13-3-126.
Abstract
Transcatheter aortic valve replacement (TAVR) has exploded into medical care for aortic stenosis, thus changing the treatment options for patients. TAVR is currently approved for extreme-risk, high-risk, and intermediate-risk patients with symptomatic severe aortic stenosis, and randomized trials for low-risk patients are underway. This article traces the trajectory of TAVR as a viable option for higher-risk patients and examines current outcomes.
摘要
经导管主动脉瓣置换术（TAVR）已迅速成为治疗主动脉瓣狭窄的医疗手段，从而改变了患者的治疗选择。目前，TAVR已被批准用于治疗有症状的严重主动脉瓣狭窄的极高危、高危和中危患者，针对低危患者的随机试验正在进行中。本文追溯了TAVR作为高危患者可行选择的发展轨迹，并审视了当前的治疗效果。
相似文献
1
Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes.
Methodist Debakey Cardiovasc J. 2017 Jul-Sep;13(3):126-131. doi: 10.14797/mdcj-13-3-126.
2
Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: A meta-analysis of randomized trials and propensity score matched observational studies.
Catheter Cardiovasc Interv. 2018 Aug 1;92(2):408-416. doi: 10.1002/ccd.27518. Epub 2018 Feb 1.
3
When to SAVR in the age of TAVR? A perspective on surgical aortic valve replacement in 2018.
Cardiovasc Revasc Med. 2018 Mar;19(2):139-141. doi: 10.1016/j.carrev.2018.03.014.
4
Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.
Circ Cardiovasc Interv. 2016 Jun;9(6). doi: 10.1161/CIRCINTERVENTIONS.115.003426.
5
Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience.
Catheter Cardiovasc Interv. 2018 Aug 1;92(2):390-398. doi: 10.1002/ccd.27478. Epub 2018 Jan 9.
6
Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial.
Circ Cardiovasc Interv. 2016 Jun;9(6). doi: 10.1161/CIRCINTERVENTIONS.115.003665.
7
Transcatheter Aortic Valve Replacement in Low-Risk Patients: A Meta-Analysis of Randomized Controlled Trials.
Cardiovasc Revasc Med. 2020 Apr;21(4):461-466. doi: 10.1016/j.carrev.2019.08.008. Epub 2019 Aug 16.
8
Computed Tomography-Based Indexed Aortic Annulus Size to Predict Prosthesis-Patient Mismatch.
Circ Cardiovasc Interv. 2019 Apr;12(4):e007396. doi: 10.1161/CIRCINTERVENTIONS.118.007396.
9
Cardiovascular Outcomes with Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients: An Updated Meta-Analysis of Randomized Controlled Trials.
Cardiovasc Revasc Med. 2020 Apr;21(4):453-460. doi: 10.1016/j.carrev.2019.08.009. Epub 2019 Aug 15.
10
Transcatheter versus surgical aortic valve replacement in low-risk surgical patients: A meta-analysis of randomized clinical trials.
Cardiovasc Revasc Med. 2019 Oct;20(10):838-842. doi: 10.1016/j.carrev.2018.12.023. Epub 2019 Jan 4.
引用本文的文献
1
Enhancing Frailty Assessments for Transcatheter Aortic Valve Replacement Patients Using Structured and Unstructured Data: Real-World Evidence Study.
JMIR Aging. 2024 Nov 27;7:e58980. doi: 10.2196/58980.
2
Treating Aortic Valve Stenosis for Vitality Improvement: The TAVI Study.
Diseases. 2024 Aug 2;12(8):175. doi: 10.3390/diseases12080175.
3
Multilayer Perceptron Neural Network Analysis of Fluoroscopic Working Angle on Transcatheter Aortic Valve Implantation Complications.
Cureus. 2024 Apr 27;16(4):e59144. doi: 10.7759/cureus.59144. eCollection 2024 Apr.
4
Structural heart disease review of TAVR in low-risk patients: importance of lifetime management.
Front Cardiovasc Med. 2024 Mar 1;11:1362791. doi: 10.3389/fcvm.2024.1362791. eCollection 2024.
5
Transcatheter aortic valve replacement in patients with chronic kidney disease: a multi-centre retrospective study.
Ann Med Surg (Lond). 2023 Dec 5;86(2):697-702. doi: 10.1097/MS9.0000000000001590. eCollection 2024 Feb.
6
Transcatheter Aortic Valve Implantation: A Report on Serbia's First Systematic Program.
Front Cardiovasc Med. 2022 May 24;9:882854. doi: 10.3389/fcvm.2022.882854. eCollection 2022.
7
Cardiac Cachexia Associated With Valvular Heart Failure.
Cureus. 2021 Dec 2;13(12):e20109. doi: 10.7759/cureus.20109. eCollection 2021 Dec.
8
Long-term Follow-up After Transcatheter Aortic Valve Replacement.
CJC Open. 2021 Feb 1;3(7):845-853. doi: 10.1016/j.cjco.2021.01.012. eCollection 2021 Jul.
9
Transcatheter Aortic Valve Implantation in Patients With Severe, Symptomatic Aortic Valve Stenosis at Intermediate Surgical Risk: A Health Technology Assessment.
Ont Health Technol Assess Ser. 2020 Mar 6;20(2):1-121. eCollection 2020.
10
Outcomes of Veterans Undergoing TAVR Within Veterans Affairs Medical Centers: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
JACC Cardiovasc Interv. 2019 Nov 11;12(21):2186-2194. doi: 10.1016/j.jcin.2019.04.040. Epub 2019 Aug 28.
本文引用的文献
1
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.
N Engl J Med. 2017 Apr 6;376(14):1321-1331. doi: 10.1056/NEJMoa1700456. Epub 2017 Mar 17.
2
Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis.
Eur Heart J. 2016 Jul 21;37(28):2252-62. doi: 10.1093/eurheartj/ehw112. Epub 2016 Mar 31.
3
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis.
Lancet. 2016 May 28;387(10034):2218-25. doi: 10.1016/S0140-6736(16)30073-3. Epub 2016 Apr 3.
4
3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement.
J Am Coll Cardiol. 2016 Jun 7;67(22):2565-74. doi: 10.1016/j.jacc.2016.03.506. Epub 2016 Apr 3.
5
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.
N Engl J Med. 2016 Apr 28;374(17):1609-20. doi: 10.1056/NEJMoa1514616. Epub 2016 Apr 2.
6
2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery.
J Am Coll Cardiol. 2015 Sep 22;66(12):1327-34. doi: 10.1016/j.jacc.2015.07.042.
7
2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement.
J Am Coll Cardiol. 2015 Jul 14;66(2):113-21. doi: 10.1016/j.jacc.2015.05.017. Epub 2015 Jun 5.
8
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.
Lancet. 2015 Jun 20;385(9986):2477-84. doi: 10.1016/S0140-6736(15)60308-7. Epub 2015 Mar 15.
9
Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years.
JAMA. 2014 Oct 1;312(13):1323-9. doi: 10.1001/jama.2014.12679.
10
Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study.
J Am Coll Cardiol. 2014 Sep 30;64(13):1339-48. doi: 10.1016/j.jacc.2014.05.067.
Zotero 插件